Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Klin Lab Diagn ; (1): 22, 35-6, 2009 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-19253696

RESUMEN

It is now known that the electric charge of a surface cellular membrane is a rather characteristic value for each type of a cell. Cellular electrophoresis may be used to study the electrokinetic properties of red blood cells in each specific case, thereby obtaining indirect information on the state of a surface membrane as the electrophoretic mobility (EPM) rate is directly proportional to the value of a cellular electric charge. The study was undertaken to compare the EPM rates of peripheral red blood cells from donors, by employing two different preservatives: EDTCHA and sodium citrate. No statistically significant differences were found in the groups under study and these parameters were comparable.


Asunto(s)
Membrana Eritrocítica/química , Conservadores Farmacéuticos/química , Electroforesis/métodos , Humanos , Preservación Biológica/métodos
4.
Vopr Med Khim ; 31(3): 26-30, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-4063012

RESUMEN

Activity of adenosine deaminase (EC 3.5.4.4) was studied in thrombocytes of donors and patients with various hematological diseases. The enzymatic activity was decreased in acute leukemia, chronic myeloleukemia, chronic leukemia and blast transformation myeloma, microspherocytic and hypoplastic anemias. Variable level of the activity was observed in chronic lympholeukemia and non-Hodgkin disease. In all the diseases studied functions of thrombocytes were altered after treatment with various aggregating agents (ADP, thrombin, collagen, adrenaline, ristomycin).


Asunto(s)
Adenosina Desaminasa/sangre , Plaquetas/enzimología , Enfermedades Hematológicas/enzimología , Nucleósido Desaminasas/sangre , Anemia/sangre , Anemia/enzimología , Enfermedades Hematológicas/sangre , Humanos , Trastornos Linfoproliferativos/sangre , Trastornos Linfoproliferativos/enzimología , Trastornos Mieloproliferativos/sangre , Trastornos Mieloproliferativos/enzimología , Agregación Plaquetaria
5.
Vopr Med Khim ; 31(2): 76-9, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-3923715

RESUMEN

Activity of purine nucleoside phosphorylase (EC 2.4.2.1) was estimated in thrombocytes of donors and of patients with various hematological diseases. The enzymatic activity was decreased in chronic lymphoid leukosis chronic myeloleukemia, chronic myeloleukemia and blast transformation, acute lymphoblast and myeloblast leukemia, myeloma. Dissimilar level of purine nucleoside phosphorylase activity was found in non-Hodgkin disease. The activity was only slightly increased in Waldenström's macroglobulinemia; it was similar to normal level in hypoplastic and autoimmune hemolytic anemias. A decrease in the enzymatic activity was observed in thrombocytes of the patients with hereditary forms of hemorrhagic diatheses (hemophilia A, Willebrand disease). Normal level of the enzymatic activity was noted in Glanzmann thrombasthenia.


Asunto(s)
Plaquetas/enzimología , Enfermedades Hematológicas/enzimología , Pentosiltransferasa/sangre , Purina-Nucleósido Fosforilasa/sangre , Donantes de Sangre , Enfermedades Hematológicas/genética , Humanos , Leucemia/enzimología
10.
Vopr Med Khim ; (3): 425-7, 1977.
Artículo en Ruso | MEDLINE | ID: mdl-888412

RESUMEN

An inhibitor of adenase, which is absent in leukemic patients, was studied in thrombocytes of healthy persons. The inhibitor, localized in the granular fraction, was isolated by ultracentrifugation in sucrose gradient.


Asunto(s)
Aminohidrolasas/antagonistas & inhibidores , Plaquetas/enzimología , Humanos , Leucemia Linfoide/sangre , Leucemia Linfoide/enzimología
12.
Probl Gematol Pereliv Krovi ; 20(6): 8-13, 1975 Jun.
Artículo en Ruso | MEDLINE | ID: mdl-1056003

RESUMEN

An attempt is made to ascertain the mechanism of increased fibrinolytic activity in patients suffering from acute leukemia. Investigations confirmed a possibility of both the primary and the secondary character of hyperfibrinolysis which required the choice of rational therapeutic tactics in each individual case.


Asunto(s)
Fibrinólisis , Hemorragia/prevención & control , Leucemia/sangre , Enfermedad Aguda , Adolescente , Adulto , Trastornos de la Coagulación Sanguínea/etiología , Femenino , Hemorragia/etiología , Humanos , Leucemia/complicaciones , Leucemia Mieloide Aguda/sangre , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...